apoQlar has raised funds in a financing round led by YZR Capital, a German venture capital firm focusing on investments in the health tech field.
The investment is said to confirm the potential of the augmented reality platform of apoQlar, VSI HoloMedicine.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
apoQlar expects the investment will help in the launch of its new software VSI HoloMedicine version 2.0, which could improve the planning of surgery, medical education and outcomes in patients.
Collaboration with YZR will aid apoQlar in improving its augmented reality technology, bolster its presence in the market and broaden its footprint globally.
The latest funds will aid apoQlar in partnering with healthcare providers and surgical teams to boost surgical practices and patient outcomes.
apoQlar CEO and co-founder Sirko Pelzl said: “This investment not only validates the potential of our augmented reality platform but also highlights the importance of our mission to improve surgical care.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“We are confident in our ability to drive innovation, expand our reach, and make a significant impact on the healthcare industry globally.”
In Singapore, the company also entered a collaboration with National University Health System (NUHS), Infocomm Media Development Authority, Microsoft and Singtel to deploy the HoloMedicine ASAP architecture as part of the NUHS HoloMedicine Programme.
